Skip to main content

Table 1 Patient characteristics

From: Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

   5-FU, Mitomycin C Gemcitabine, Cisplatin
   patients % patients %
All patients   35   58  
Age Median (Range) 63 (37 - 75) 63 (35 - 76)
Gender Male 23 66 36 62
  Female 12 34 22 38
Surgery No resection 26 74 41 71
  resection 9 26 15 29
Tumour location Head 25 71 40 69
  Head/Body 3 9 5 9
  Body 5 14 9 16
  Body and tail 1 3 3 5
  tail - - 1 2
cT 1997 1 1 3 2 3
  2 8 23 8 14
  3 8 23 16 28
  4 18 51 32 55
cN 1997 0 15 43 27 47
  1 20 57 31 53
UICC 1997 I 4 11 7 12
  II 3 9 7 12
  III 9 26 12 20
  IVa 17 49 31 53
  IVb 2 6 1 1
Grading 1 3 9 3 5
  2 15 43 28 48
  3 5 14 16 28
  4 0 - 0 -
  1. Abbreviations: R0 = clear resection, R1 = positive margin, RX = resection margin uncertain.